Trial
NCT01346930
Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Actelion
Collaborators
—
Condition
Idiopathic Pulmonary Fibrosis
Intervention
Macitentan
Why stopped
Due to Protocol AC-055B201 (MUSIC) not meeting it's primary end point
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-22